Vol 94, No 4 (2023)
Research paper
Published online: 2023-02-17

open access

Page views 2193
Article views/downloads 495
Get Citation

Connect on Social Media

Connect on Social Media

Novel marker to predict rupture risk in tubal ectopic pregnancies: the systemic immune-inflammation index

Kemal Dinc1, Gizem Issın2
Pubmed: 36929797
Ginekol Pol 2023;94(4):320-325.

Abstract

Objectives: Ectopic pregnancy is a life-threatening condition; delaying treatment can result in mortality or serious complications. Identification of a biomarker that can predict tubal rupture may be helpful for guiding treatment. In this study, we evaluated the association between serum β-hCG, biochemical markers, Systemic Immunity-inflammation Index (SII) score, and the trophoblastic invasion stage.
Material and methods: Tubal pregnancy was classified into three groups based on the depth of trophoblastic infiltration: stage I — limited to the mucosa; stage II — invaded the muscular layer, and stage III — invaded the serosa/subserosa of the tuba uterine. The association between groups, serum β-hCG, biochemical markers, and the SII score were assessed.
Results: There was no significant difference between the groups, hemoglobin, platelet count, MPV, RDW, NLR or PLR values (p > 0.05). A ROC analysis was performed to evaluate the accuracy of serum β-hCG predictions for infiltration level. At a 95% confidence interval upper limit, cut-off value of the serum β-hCG that best predicted stage III trophoblastic infiltration, was 2799 mIU/mL, with 78.9% sensitivity, 53.8% specificity (positive predictive value was 71.4%, and a negative predictive value was 63.6%). Moreover, ROC curve analysis showed that The SII value of 792 was the best predictor of trophoblastic infiltration at stage III, with a sensitivity of 92.3% and a specificity of 63.1%.
Conclusions: A linear relationship exists between depth of trophoblastic infiltration and serum β-hCG and the SII were observed. These findings suggested that the SII score can be used for predicting tubal ectopic pregnancy rupture.

Article available in PDF format

View PDF Download PDF file

References

  1. Al Naimi A, Moore P, Brüggmann D, et al. Ectopic pregnancy: a single-center experience over ten years. Reprod Biol Endocrinol. 2021; 19(1): 79.
  2. Garcia Grau E, Checa Vizcaíno MÁ, Oliveira M, et al. The Value of Hysterosalpingography following Medical Treatment with Methotrexate for Ectopic Pregnancy. Obstet Gynecol Int. 2011; 2011: 547946.
  3. Bouyer J, Coste J, Fernandez H, et al. Sites of ectopic pregnancy: a 10 year population-based study of 1800 cases. Hum Reprod. 2002; 17(12): 3224–3230.
  4. Alkatout I, Honemeyer U, Strauss A, et al. Clinical diagnosis and treatment of ectopic pregnancy. Obstet Gynecol Surv. 2013; 68(8): 571–581.
  5. Dvash S, Cuckle H, Smorgick N, et al. Increase rate of ruptured tubal ectopic pregnancy during the COVID-19 pandemic. Eur J Obstet Gynecol Reprod Biol. 2021; 259: 95–99.
  6. Karaman E, Çim N, Alkış İ, et al. Evaluation of mean platelet volume in unruptured ectopic pregnancy: A retrospective analysis. J Obstet Gynaecol. 2016; 36(5): 622–625.
  7. Artunc Ulkumen B, Pala HG, Calik E, et al. Can Mean Platelet Volume and Platelet Distrubition Width be Possible Markers for Ectopic Pregnancy and Tubal Rupture? (MPV and PDW in Ectopic Pregnancy). Pak J Med Sci. 2014; 30(2): 352–355.
  8. Tanacan A, Uyanik E, Unal C, et al. A cut-off value for systemic immune-inflammation index in the prediction of adverse neonatal outcomes in preterm premature rupture of the membranes. J Obstet Gynaecol Res. 2020; 46(8): 1333–1341.
  9. Elito J, Ferreira DF, Araujo Júnior E, et al. Values of beta-human chorionic gonadotrofin as a risk factor for tubal pregnancy rupture evaluated by histopathology. J Matern Fetal Neonatal Med. 2014; 27(6): 637–639.
  10. Walzik D, Joisten N, Zacher J, et al. Transferring clinically established immune inflammation markers into exercise physiology: focus on neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and systemic immune-inflammation index. Eur J Appl Physiol. 2021; 121(7): 1803–1814.
  11. Turgut EN, Celik E, Celik S, et al. Could serum β-hCG levels and gestational age be the indicative factors for the prediction of the degree of trophoblastic invasion into tubal wall in unruptured ampullary pregnancies? Arch Gynecol Obstet. 2013; 287(2): 323–328.
  12. Turgut E, Yildirim M, Sakcak B, et al. Predicting miscarriage using systemic immune-inflammation index. J Obstet Gynaecol Res. 2022; 48(3): 587–592.
  13. Darkhaneh RF, Asgharnia M, Porkar NF, et al. Predictive value of maternal serum β-hCG concentration in the ruptured tubal ectopic pregnancy . Iran J Reprod Med. 2015; 13(2): 101–106.
  14. Walzik D, Joisten N, Zacher J, et al. Transferring clinically established immune inflammation markers into exercise physiology: focus on neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and systemic immune-inflammation index. Eur J Appl Physiol. 2021; 121(7): 1803–1814.
  15. Shaw JLV, Dey SK, Critchley HOD, et al. Current knowledge of the aetiology of human tubal ectopic pregnancy. Hum Reprod Update. 2010; 16(4): 432–444.
  16. Turgut A, Sak ME, Ozler A, et al. Alteration of peripheral blood cells in tubal ectopic pregnancy. Ginekol Pol. 2013; 84(3): 193–196.